Interleukin-4 impairs granzyme-mediated cytotoxicity of Simian virus 40 large tumor antigen-specific CTL in BALB/c mice

Cancer Immunology, Immunotherapy

Volumn 56, Issue 10, 2007, Pages 1625-1636

  Baschuk, Nikola ^a   Utermöhlen, Olaf ^a   Gugel, Roland ^b,d   Warnecke, Gabriele ^b   Karow, Ulrike ^a   Paulsen, Daniela ^b,e   Brombacher, Frank ^c   Krönke, Martin ^a   Deppert, Wolfgang ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d POLYGENE AG   (Switzerland)

^e AiCuris GmbH   (Germany)

Author keywords

CTL; Granzymes; IL 4; Tumor specific antigen

Indexed keywords

GRANZYME A; GRANZYME B; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; CANCER CELL CULTURE; CANCER GRAFT; CANCER GROWTH; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; ISOGRAFT; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIMIAN VIRUS 40; SURVIVAL TIME; TUMOR IMMUNITY; WILD TYPE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, POLYOMAVIRUS TRANSFORMING; ANTIGENS, VIRAL, TUMOR; CELL LINE, TRANSFORMED; CYTOTOXICITY, IMMUNOLOGIC; GRANZYMES; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33947584468     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0309-0     Document Type: Article

References (55)

1. Seder RA, Paul WE (1994) Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 12:635-673
2. Widmer MB, Grabstein KH (1987) Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor. Nature 326:795-798
3. Trenn G, Takayama H, Hu-Li J, Paul WE, Sitkovsky MV (1988) B cell stimulatory factor 1 (IL-4) enhances the development of cytotoxic T cells from Lyt-2+ resting murine T lymphocytes. J Immunol 140:1101-1106
4. Miller CL, Hooton JW, Gillis S, Paetkau V (1990) IL-4 potentiates the IL-2-dependent proliferation of mouse cytotoxic T cells. J Immunol 144:1331-1337
5. Erard F, Wild MT, Garcia-Sanz JA, Le Gros G (1993) Switch of CD8 T cells to noncytolytic CD8-CD4-cells that make TH2 cytokines and help B cells. Science 260:1802-1805
6. Croft M, Carter L, Swain SL, Dutton RW (1994) Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 180:1715-1728
7. Noble A, Macary PA, Kemeny DM (1995) IFN-gamma and IL-4 regulate the growth and differentiation of CD8+ T cells into subpopulations with distinct cytokine profiles. J Immunol 155:2928-2937
8. Moran TM, Isobe H, Fernandez-Sesma A, Schulman JL (1996) Interleukin-4 causes delayed virus clearance in influenza virus-infected mice. J Virol 70:5230-5235
9. Sharma DP, Ramsay AJ, Maguire DJ, Rolph MS, Ramshaw IA (1996) Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol 70:7103-7107
10. Aung S, Tang YW, Graham BS (1999) Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo. J Virol 73:8944-8949
11. Matsunaga K, Nakao M, Masuoka K, Inoue Y, Gouhara R, Imaizumi T, Nishizaka S, Itoh K (1999) Cytokines required for induction of histocompatibility leukocyte antigen-class I-restricted and tumor-specific cytotoxic T lymphocytes by a SART1-derived peptide. Jpn J Cancer Res 90:1007-1015
12. Rodolfo M, Zilocchi C, Accornero P, Cappetti B, Arioli I, Colombo MP (1999) IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer. J Immunol 163:1923-1928
13. Villacres MC, Bergmann CC (1999) Enhanced cytotoxic T cell activity in IL-4-deficient mice. J Immunol 162:2663-2670
14. Aleman M, De La Barrera S, Fink S, Finiasz M, Farina MH, Pizzariello G, Sasiain MD (2000) Interleukin-12 amplifies the M. leprae hsp65-cytotoxic response in the presence of tumour necrosis factor-alpha and interferon-gamma generating CD56+ effector cells: interleukin-4 downregulates this effect. Scand J Immunol 51:262-270
15. Liu Y, Zhang W, Chan T, Saxena A, Xiang J (2002) Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity. Leuk Res 26:757-763
16. Rolph MS, Ramshaw IA (2003) Interleukin-4-mediated downregulation of cytotoxic T lymphocyte activity is associated with reduced proliferation of antigen-specific CD8+ T cells. Microbes Infect 5:923-932
17. Aung S, Graham BS (2000) IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo. J Immunol 164:3487-3493
18. Jackson RJ, Ramsay AJ, Christensen CD, Beaton S, Hall DF, Ramshaw IA (2001) Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol 75:1205-1210
19. Tang YW, Graham BS (1994) Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J Clin Invest 94:1953-1958
20. Mo XY, Sangster MY, Tripp RA, Doherty PC (1997) Modification of the Sendai virus-specific antibody and CD8+ T-cell responses in mice homozygous for disruption of the interleukin-4 gene. J Virol 71:2518-2521
21. Bachmann MF, Schorle H, Kuhn R, Muller W, Hengartner H, Zinkernagel RM, Horak I (1995) Antiviral immune responses in mice deficient for both interleukin-2 and interleukin-4. J Virol 69:4842-4846
22. Zerrahn J, Utermohlen O, Warnecke G, Deppert W, Lehmann-Grube F (1996) Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes. J Immunol 156:3919-3924
23. Utermohlen O, Schulze-Garg C, Warnecke G, Gugel R, Lohler J, Deppert W (2001) Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells. J Virol 75:10593-10602
24. Bright RK, Beames B, Shearer MH, Kennedy RC (1996) Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen. Cancer Res 56:1126-1130
25. Gooding LR (1977) Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells. J Immunol 118:920-927
26. Knowles BB, Koncar M, Pfizenmaier K, Solter D, Aden DP, Trinchieri G (1979) Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen. J Immunol 122:1798-1806
27. Newmaster RS, Mylin LM, Fu TM, Tevethia SS (1998) Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection. Virology 244:427-441
28. Schirmbeck R, Bohm W, Reimann J (1996) DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors. J Immunol 157:3550-3558
29. Tevethia SS (1990) Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes. Mol Biol Med 7:83-96
30. Pfizenmaier K, Pan SH, Knowles BB (1980) Preferential H-2 association in cytotoxic T cell responses to SV40 tumor-associated specific antigens. J Immunol 124:1888-1891
31. Tevethia SS, Lewis M, Tanaka Y, Milici J, Knowles B, Maloy WL, Anderson R (1990) Dissection of H-2Db-restricted cytotoxic T-lymphocyte epitopes on simian virus 40 T antigen by the use of synthetic peptides and H-2Dbm mutants. J Virol 64:1192-1200
32. Noben-Trauth N, Kohler G, Burki K, Ledermann B (1996) Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res 5:487-491
33. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G (1993) Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245-248
34. Kopf M, Brombacher F, Kohler G, Kienzle G, Widmann KH, Lefrang K, Humborg C, Ledermann B, Solbach W (1996) IL-4-deficient Balb/c mice resist infection with Leishmania major. J Exp Med 184:1127-1136
35. Kit S, Kurimura T, Dubbs DR (1969) Transplantable mouse tumor line induced by injection of SV40-transformed mouse kidney cells. Int J Cancer 4:384-392
36. Flood PM, DeLeo AB, Old LJ, Gershon RK (1983) Relation of cell surface antigens on methylcholanthrene-induced fibrosarcomas to immunoglobulin heavy chain complex variable region-linked T cell interaction molecules. Proc Natl Acad Sci USA 80:1683-1687
37. Gurney EG, Tamowski S, Deppert W (1986) Antigenic binding sites of monoclonal antibodies specific for simian virus 40 large T antigen. J Virol 57:1168-1172
38. Gegin C, Lehmann-Grube F (1992) Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope. J Immunol 149:3331-3338
39. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R (2003) Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 4:1191-1198
40. Janas ML, Groves P, Kienzle N, Kelso A (2005) IL-2 regulates perforin and granzyme gene expression in CD8+ T cells independently of its effects on survival and proliferation. J Immunol 175:8003-8010
41. Ebnet K, Hausmann M, Lehmann-Grube F, Mullbacher A, Kopf M, Lamers M, Simon MM (1995) Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. Embo J 14:4230-4239
42. Sharma V, Delgado M, Ganea D, Granzyme B (2006) A new player in activation-induced cell death, is down-regulated by vasoactive intestinal peptide in Th2 but not Th1 effectors. J Immunol 176:97-110
43. Murphy KM, Reiner SL (2002) The lineage decisions of helper T cells. Nat Rev Immunol 2:933-944
44. Agnello D, Lankford CS, Bream J, Morinobu A, Gadina M, O'Shea JJ, Frucht DM (2003) Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 23:147-161
45. Bright RK, Shearer MH, Kennedy RC (1995) Examination of lymphokines induced in mice following immunization with recombinant simian virus 40 large tumor antigen. Cancer Immunol Immunother 40:206-211
46. Gallimore A, Glithero A, Godkin A, Tissot AC, Pluckthun A, Elliott T, Hengartner H, Zinkernagel R (1998) Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med 187:1383-1393
47. Klein L, Trautman L, Psarras S, Schnell S, Siermann A, Liblau R, von Boehmer H, Khazaie K (2003) Visualizing the course of antigen-specific CD8 and CD4 T cell responses to a growing tumor. Eur J Immunol 33:806-814
48. Blank C, Mackensen A (2006) Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion. Cancer Immunol Immunother
49. Olver S, Groves P, Buttigieg K, Morris ES, Janas ML, Kelso A, Kienzle N (2006) Tumor-derived interleukin-4 reduces tumor clearance and deviates the cytokine and granzyme profile of tumor-induced CD8+ T cells. Cancer Res 66:571-580
50. Kienzle N, Buttigieg K, Groves P, Kawula T, Kelso A (2002) A clonal culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T cells with low CD8, perforin, and granzyme expression. J Immunol 168:1672-1681
51. Kienzle N, Baz A, Kelso A (2004) Profiling the CD8low phenotype, an alternative career choice for CD8 T cells during primary differentiation. Immunol Cell Biol 82:75-83
52. Kienzle N, Olver S, Buttigieg K, Groves P, Janas ML, Baz A, Kelso A (2005) Progressive differentiation and commitment of CD8+ T cells to a poorly cytolytic CD8 low phenotype in the presence of IL-4. J Immunol 174:2021-2029
53. Schuler T, Kammertoens T, Preiss S, Debs P, Noben-Trauth N, Blankenstein T (2001) Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8(+) T cells. J Exp Med 194:1767-1775
54. Schuler T, Qin Z, Ibe S, Noben-Trauth N, Blankenstein T (1999) T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. J Exp Med 189:803-810
55. Kataoka T, Shinohara N, Takayama H, Takaku K, Kondo S, Yonehara S, Nagai K (1996) Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 156:3678-3686